Paragon Associates & Paragon Associates Ii Joint Venture Akoya Biosciences, Inc. Transaction History
Paragon Associates & Paragon Associates Ii Joint Venture
- $58.7 Million
- Q2 2025
A detailed history of Paragon Associates & Paragon Associates Ii Joint Venture transactions in Akoya Biosciences, Inc. stock. As of the latest transaction made, Paragon Associates & Paragon Associates Ii Joint Venture holds 671,000 shares of AKYA stock, worth $865,590. This represents 1.49% of its overall portfolio holdings.
Number of Shares
671,000
Previous 671,000
-0.0%
Holding current value
$865,590
Previous $932,000
6.44%
% of portfolio
1.49%
Previous 2.35%
Shares
4 transactions
Others Institutions Holding AKYA
# of Institutions
58Shares Held
13.8MCall Options Held
0Put Options Held
14K-
Blue Water Life Science Advisors, LP Larkspur, CA4.7MShares$6.06 Million4.83% of portfolio
-
Oddo Bhf Asset Management Sas Paris, I01.89MShares$2.44 Million0.1% of portfolio
-
Black Rock Inc. New York, NY1.5MShares$1.94 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.19MShares$1.54 Million0.0% of portfolio
-
Trium Capital LLP London, X0605KShares$781,0890.09% of portfolio
About Akoya Biosciences, Inc.
- Ticker AKYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 37,892,300
- Market Cap $48.9M
- Description
- Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope...